MSI2 modulates pancreatic cancer development through directly binding to the mRNAs of SAV1 and MOB1, thereby controlling the translation and stability of SAV1, as well as the translation of MOB1 [41]. This evidence concerns the gene SAV1 and familial pancreatic carcinoma.